ADHD: why a careful evaluation matters

Attention problems rarely have a single cause

The overlap is larger than most people realize. In adults with ADHD, anxiety disorders are roughly five times more common, depression about four and a half times, bipolar disorder nearly nine times, and substance-use disorders about four and a half times more common than in other adults. Around 60% screen positive for at least one sleep disorder. And sleep deprivation on its own can produce inattention and executive-function problems that are essentially indistinguishable from ADHD in an interview. So 'I can't focus' has a long list of possible drivers — and often more than one is involved at once.

Why an accurate diagnosis reaches back to childhood

Diagnostic criteria (DSM-5-TR) require that symptoms were present before age 12 and that they impair functioning in two or more settings — work, home, relationships. For an adult who was never diagnosed as a child, establishing that takes a careful developmental history. This matters because self-report checklists, like the ASRS, have adequate sensitivity but poor specificity: used alone, they produce high false-positive rates. That's exactly why guidelines recommend gathering records, school history, or input from people who have known you a long time. It isn't gatekeeping — it's what protects the accuracy of the diagnosis.

What a careful ADHD evaluation looks at

A thorough evaluation weighs onset and developmental history; evidence of real impairment across more than one area of life; and the conditions that imitate or accompany ADHD — sleep disorders, mood and anxiety disorders, trauma, substance-use risk, medical contributors, and medication effects. Records are reviewed when relevant, and when the picture stays unclear, neuropsychological testing can add objective measures. The point is to separate ADHD from its mimics, and to find them when they coexist.

Stimulants work — which is exactly why the diagnosis has to be right

Stimulants are first-line and genuinely effective: roughly 70% of adults with correctly diagnosed ADHD improve, often substantially. That effectiveness is the reason precision matters. Stimulants are also Schedule II controlled substances — over 3.4 million U.S. adults misused prescription stimulants in 2021. The published standard of care includes checking the state prescription-monitoring database (PDMP) before prescribing, a controlled-substance agreement, reevaluation at least every three months with heart-rate and blood-pressure monitoring, and a preference for extended-release formulations, which are harder to misuse. None of this is about making you prove yourself; it's the established safe-prescribing framework.

There are non-stimulant options too

Stimulants aren't the only path. For people who can't take them — because of heart conditions, a history of substance use, or personal preference — or who have co-occurring anxiety, non-stimulant medications (atomoxetine, viloxazine, bupropion) carry lower misuse potential and can sometimes ease anxiety as well. A good plan fits the medication to the whole person, not the other way around.

The goal is the right answer, not a label

The purpose of a careful evaluation is not to force one diagnosis or to withhold treatment. It is to understand what is actually driving the attention and functioning problems — and then to choose a safe, effective next step, whether that's stimulant medication with proper monitoring, a non-stimulant, treating an underlying sleep or mood problem, or some combination. An accurate answer is what makes treatment work.

Related service